These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 23532518

  • 1. CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2.
    Provost V, Larose MC, Langlois A, Rola-Pleszczynski M, Flamand N, Laviolette M.
    J Leukoc Biol; 2013 Aug; 94(2):213-22. PubMed ID: 23532518
    [Abstract] [Full Text] [Related]

  • 2. Editorial: are all eotaxins created equal?
    Pease JE, Williams TJ.
    J Leukoc Biol; 2013 Aug; 94(2):207-9. PubMed ID: 23906965
    [No Abstract] [Full Text] [Related]

  • 3. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
    White JR, Lee JM, Dede K, Imburgia CS, Jurewicz AJ, Chan G, Fornwald JA, Dhanak D, Christmann LT, Darcy MG, Widdowson KL, Foley JJ, Schmidt DB, Sarau HM.
    J Biol Chem; 2000 Nov 24; 275(47):36626-31. PubMed ID: 10969084
    [Abstract] [Full Text] [Related]

  • 4. Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation.
    Abonyo BO, Alexander MS, Heiman AS.
    Am J Physiol Lung Cell Mol Physiol; 2005 Sep 24; 289(3):L478-88. PubMed ID: 15863444
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis.
    Ahmadi Z, Hassanshahi G, Khorramdelazad H, Zainodini N, Koochakzadeh L.
    Inflammation; 2016 Jun 24; 39(3):1253-67. PubMed ID: 26861136
    [Abstract] [Full Text] [Related]

  • 9. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T, Suzuki K, Masunaga Y, Taguchi K, Morihira K, Sato I, Fujii M, Takizawa S, Torii Y, Yamamoto N, Kaneko M, Yamada T, Takahashi K, Shimizu Y.
    J Pharmacol Exp Ther; 2006 Apr 24; 317(1):244-50. PubMed ID: 16339911
    [Abstract] [Full Text] [Related]

  • 10. Control of extravillous trophoblast function by the eotaxins CCL11, CCL24 and CCL26.
    Chau SE, Murthi P, Wong MH, Whitley GS, Brennecke SP, Keogh RJ.
    Hum Reprod; 2013 Jun 24; 28(6):1497-507. PubMed ID: 23477905
    [Abstract] [Full Text] [Related]

  • 11. Regulatory effects of eotaxin, eotaxin-2, and eotaxin-3 on eosinophil degranulation and superoxide anion generation.
    Badewa AP, Hudson CE, Heiman AS.
    Exp Biol Med (Maywood); 2002 Sep 24; 227(8):645-51. PubMed ID: 12192108
    [Abstract] [Full Text] [Related]

  • 12. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C, Castro-Faria-Neto HC, Vieira-de-Abreu A, Figueiredo RT, Pelled A, Martins MA, Jose PJ, Williams TJ, Bozza PT.
    Am J Respir Cell Mol Biol; 2001 Dec 24; 25(6):707-16. PubMed ID: 11726396
    [Abstract] [Full Text] [Related]

  • 13. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.
    Amerio P, Frezzolini A, Feliciani C, Verdolini R, Teofoli P, De Pità O, Puddu P.
    Curr Drug Targets Inflamm Allergy; 2003 Mar 24; 2(1):81-94. PubMed ID: 14561178
    [Abstract] [Full Text] [Related]

  • 14. Ontogeny of the eotaxins in human lung.
    Haley KJ, Sunday ME, Porrata Y, Kelley C, Twomey A, Shahsafaei A, Galper B, Sonna LA, Lilly CM.
    Am J Physiol Lung Cell Mol Physiol; 2008 Feb 24; 294(2):L214-24. PubMed ID: 18055844
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CCL11 (Eotaxin) induces CCR3-dependent smooth muscle cell migration.
    Kodali RB, Kim WJ, Galaria II, Miller C, Schecter AD, Lira SA, Taubman MB.
    Arterioscler Thromb Vasc Biol; 2004 Jul 24; 24(7):1211-6. PubMed ID: 15130922
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of eotaxin 1/CCL11, eotaxin 2/CCL24 and eotaxin 3/CCL26 expression in lesional and non-lesional skin of patients with atopic dermatitis.
    Owczarek W, Paplińska M, Targowski T, Jahnz-Rózyk K, Paluchowska E, Kucharczyk A, Kasztalewicz B.
    Cytokine; 2010 May 24; 50(2):181-5. PubMed ID: 20236835
    [Abstract] [Full Text] [Related]

  • 20. CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy.
    Errahali YJ, Taka E, Abonyo BO, Heiman AS.
    J Interferon Cytokine Res; 2009 Apr 24; 29(4):227-39. PubMed ID: 19203252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.